Cornell Clinical Trials Unit

Living with HIV has gotten a lot easier. With longer lifespans, however, we face a new set of challenges.

Founded in 1986, the Cornell Clinical Trials Unit (CCTU) has conducted landmark studies resulting in effective therapies for HIV - from AZT to protease inhibitors - as well as for the treatment and prevention of opportunistic infections.

Located in close proximity to the Center for Special Studies, the New York Presbyterian Hospital's adult outpatient HIV clinic, the CCTU operates an additional off-site location in the Chelsea section of New York City, adjacent to the Gay Men's Health Crisis.

Functioning as a community-based organization, the CCTU continually works to serve a patient population that reflects the face of the HIV/AIDS epidemic in New York City and has a strong record of enrolling: women, people of color, and people exposed to HIV through needle sharing.

We are dedicated to improving the treatments and the standards of care for HIV disease and its complications through the conduct of high-quality clinical research and the dissemination of critical research results. The CCTU is a program of the Division of International Medicine and Infectious Diseases in the Department of Medicine of the Weill Medical College of Cornell University.

The CCTU conducts many studies that are sponsored by the ACTG (AIDS Clinical Trials Group). This group is funded by the Division of AIDS, National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIH).